GSC
CNSP icon

Ground Swell Capital’s CNS Pharmaceuticals CNSP Stock Holding History

Ground Swell Capital’s Portfolio CNSP Stock Details CNSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-945
Closed -$15.4K – 163
2025
Q1 		$15.4K Buy
+945
New +$46.2K 0.03% 133

Other funds holding CNSP

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BC
Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Ground Swell Capital's CNSP Position: Q2 2025 in Review

Ground Swell Capital sold out of CNS Pharmaceuticals (CNSP) in Q2 2025, closing a stake of 945 shares — an estimated $15.4K sold.

Ground Swell Capital first reported a position in CNSP in Q1 2025 and held it in 1 quarter. The position peaked at $15.4K in Q1 2025. 11 funds tracked by Wall St. Rank hold CNSP as of Q2 2025.

  • Ground Swell Capital reported no remaining CNS Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Ground Swell Capital sold 945 CNS Pharmaceuticals shares in Q2 2025, an estimated $15.4K.
  • Ground Swell Capital first reported a position in CNS Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Ground Swell Capital's CNS Pharmaceuticals position peaked at $15.4K in Q1 2025.
  • 11 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q2 2025.

Based on Ground Swell Capital's 13F filing for Q2 2025, filed 31 Jul 2025.